Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Israel | 14 | 2022 | 796 | 1.160 |
Why?
|
Immunization, Secondary | 3 | 2022 | 340 | 0.930 |
Why?
|
Osteoporotic Fractures | 2 | 2020 | 401 | 0.910 |
Why?
|
Myocarditis | 4 | 2022 | 771 | 0.830 |
Why?
|
Mass Vaccination | 3 | 2021 | 105 | 0.790 |
Why?
|
Models, Statistical | 2 | 2021 | 5101 | 0.530 |
Why?
|
Vaccines | 1 | 2022 | 823 | 0.460 |
Why?
|
Hip Fractures | 2 | 2020 | 955 | 0.420 |
Why?
|
Risk Assessment | 6 | 2022 | 23336 | 0.370 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.350 |
Why?
|
Algorithms | 2 | 2021 | 13882 | 0.320 |
Why?
|
Calibration | 2 | 2020 | 816 | 0.270 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 634 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.210 |
Why?
|
ROC Curve | 2 | 2020 | 3528 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.210 |
Why?
|
Lactams | 1 | 2022 | 156 | 0.200 |
Why?
|
Leucine | 1 | 2022 | 560 | 0.190 |
Why?
|
Proline | 1 | 2022 | 458 | 0.190 |
Why?
|
Sex Distribution | 2 | 2021 | 2297 | 0.170 |
Why?
|
Age Distribution | 2 | 2021 | 2902 | 0.160 |
Why?
|
Fractures, Compression | 1 | 2020 | 133 | 0.160 |
Why?
|
Adolescent | 10 | 2022 | 85779 | 0.150 |
Why?
|
Incidence | 5 | 2022 | 20952 | 0.150 |
Why?
|
Nitriles | 1 | 2022 | 955 | 0.150 |
Why?
|
Young Adult | 7 | 2022 | 56429 | 0.150 |
Why?
|
Automation | 1 | 2020 | 584 | 0.150 |
Why?
|
Humans | 33 | 2022 | 744366 | 0.150 |
Why?
|
Middle Aged | 15 | 2022 | 213390 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20130 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6539 | 0.140 |
Why?
|
Adult | 15 | 2022 | 214052 | 0.140 |
Why?
|
Maternal Age | 1 | 2018 | 802 | 0.130 |
Why?
|
Area Under Curve | 1 | 2020 | 1655 | 0.130 |
Why?
|
HLA Antigens | 1 | 2021 | 1382 | 0.130 |
Why?
|
Aged, 80 and over | 5 | 2021 | 57776 | 0.130 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1978 | 0.130 |
Why?
|
Thromboembolism | 1 | 2021 | 987 | 0.130 |
Why?
|
Hospitalization | 7 | 2022 | 10259 | 0.130 |
Why?
|
Hepacivirus | 1 | 2022 | 1379 | 0.120 |
Why?
|
Aged | 10 | 2022 | 163288 | 0.120 |
Why?
|
Retrospective Studies | 10 | 2022 | 77460 | 0.120 |
Why?
|
Female | 15 | 2022 | 380193 | 0.110 |
Why?
|
Spinal Fractures | 1 | 2020 | 696 | 0.110 |
Why?
|
RNA, Messenger | 3 | 2022 | 13035 | 0.110 |
Why?
|
Male | 13 | 2022 | 350115 | 0.100 |
Why?
|
Metabolic Diseases | 1 | 2018 | 658 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1591 | 0.100 |
Why?
|
Cohort Studies | 4 | 2021 | 40559 | 0.100 |
Why?
|
Forecasting | 1 | 2020 | 2951 | 0.100 |
Why?
|
Cardiomegaly | 1 | 2014 | 620 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15160 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1832 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.090 |
Why?
|
Risk Factors | 7 | 2022 | 72296 | 0.090 |
Why?
|
Odds Ratio | 1 | 2021 | 9849 | 0.080 |
Why?
|
Parents | 1 | 2022 | 3405 | 0.080 |
Why?
|
Child | 5 | 2022 | 77709 | 0.080 |
Why?
|
Thrombosis | 1 | 2021 | 2968 | 0.080 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12244 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2022 | 63107 | 0.070 |
Why?
|
Pandemics | 3 | 2022 | 8385 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 12952 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12356 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2018 | 2861 | 0.060 |
Why?
|
Bone Density | 1 | 2017 | 3468 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 29060 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2018 | 4468 | 0.060 |
Why?
|
Child, Preschool | 2 | 2022 | 41005 | 0.050 |
Why?
|
Pregnancy | 2 | 2021 | 29144 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6486 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 5023 | 0.050 |
Why?
|
Vaccination | 2 | 2022 | 3279 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18373 | 0.040 |
Why?
|
Histocompatibility Testing | 1 | 2021 | 741 | 0.040 |
Why?
|
Delivery of Health Care | 3 | 2022 | 5321 | 0.040 |
Why?
|
Stroke | 1 | 2021 | 9981 | 0.040 |
Why?
|
Herpes Zoster | 1 | 2021 | 264 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2022 | 402 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19905 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10895 | 0.040 |
Why?
|
Drug Combinations | 1 | 2022 | 1958 | 0.040 |
Why?
|
Family Characteristics | 1 | 2022 | 1000 | 0.040 |
Why?
|
Obesity | 1 | 2018 | 12746 | 0.030 |
Why?
|
Appendicitis | 1 | 2021 | 645 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2779 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4751 | 0.030 |
Why?
|
Isoproterenol | 1 | 2014 | 399 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15535 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21696 | 0.030 |
Why?
|
Social Class | 1 | 2021 | 1997 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2703 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 625 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3177 | 0.020 |
Why?
|
Pressure | 1 | 2014 | 1203 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2073 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2022 | 4576 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6933 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9688 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5099 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5755 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3954 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 3001 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5253 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15078 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15221 | 0.020 |
Why?
|
United States | 2 | 2022 | 69872 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2916 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21748 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Myocardium | 1 | 2014 | 4772 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13286 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53290 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39052 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81201 | 0.000 |
Why?
|
Animals | 1 | 2014 | 168768 | 0.000 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_